Skip to main content
. 2021 May 24;22(1):556. doi: 10.3892/ol.2021.12817

Figure 2.

Figure 2.

Enhanced migration and invasion of 827/IcoR and PC9/IcoR cells. (A) Wound healing assay was performed to test the migration of parent cells (HCC827 and PC9) and resistant cells (827/IcoR and PC9/IcoR) with or without icotinib treatment. (B and C) Transwell migration and invasion assays of HCC827, 827/IcoR, PC9 and PC9/IcoR with or without icotinib treatment (magnification, ×200). *P<0.05 and **P<0.01. IcoR, icotinib-resistant. n.s., not significant; IcoR, icotinib-resistant.